newsfilter
← Latest News
GlobeNewswire·

Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update

TRUDHESA™ New Drug Application (NDA) Under Review by U.S. Food & Drug Administration (FDA) with PDUFA Target Action Date of September 6, 2021 Preparations On Track for Potential TRUDHESA Launch in the Fourth Quarter of 2021 Increased Cash Po